Roxane Laboratories, Inc. announced the approval of its Abbreviated New Drug Application (ANDA) for Calcium Acetate Capsules, 667mg by the U.S. Food and Drug Administration. The product is available in bottles of 200 capsules for immediate shipment to wholesalers and pharmacies nationwide.

Roxane Laboratories' Calcium Acetate Capsules, 667mg are AB rated to PhosLo® (calcium acetate) capsules. Annual sales of Calcium Acetate Capsules, 667mg are approximately $84.8 Million.

Full prescribing information for Calcium Acetate Capsules, 667mg is available on the Roxane Laboratories website at www.Roxane.com or upon request by calling Roxane Laboratories Technical Product Information at 1.800.962.8364.